Expert Perspectives in Lymphoma

Expert Perspectives in Lymphoma

Episodes

Specialty:

All

Year:

All

EP. 1: ECHELON-1 Trial: Significance in Hodgkin Lymphoma

January 26th 2018

EP. 2: Hodgkin Lymphoma: Using Brentuximab Vedotin Frontline

January 26th 2018

EP. 3: Hodgkin Lymphoma: Important Findings from CheckMate 205

January 26th 2018

EP. 4: Hodgkin Lymphoma: Addressing the Elderly Population

January 26th 2018

EP. 5: Novel Combinations in Relapsed Hodgkin Lymphoma

January 26th 2018

EP. 6: Role of Novel Therapies in Hodgkin Lymphoma

January 26th 2018

EP. 7: Primary Cutaneous T-cell Lymphoma: ALCANZA Trial

January 26th 2018

EP. 8: MAVORIC Trial in Cutaneous T-Cell Lymphoma

January 26th 2018

EP. 9: Follicular Lymphoma: Obinutuzumab and Chemotherapy

January 26th 2018

EP. 10: Long-Term Data With Copanlisib in Follicular Lymphoma

January 26th 2018

EP. 11: Duration of Rituximab Maintenance in FL

January 26th 2018

EP. 12: Approval of Acalabrutinib in Mantle Cell Lymphoma

January 26th 2018

EP. 13: Investigating CAR T-Cell Therapy in Lymphoma

January 26th 2018

EP. 14: Advances and Research Needs in Lymphoma

January 26th 2018

Trending on OncLive

Five Under 5: Top Oncology Videos for the Week of 8/31/26

FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer

B7-H4–Targeted ADCs Signal a New Frontier for Platinum-Resistant Ovarian and Endometrial Cancer

Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC

The OncFive: Top Oncology Articles for the Week of 8/30